ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
来凯医药-B
16.240
-0.420
-2.52%
手动刷新
成交量:
908.60万
成交额:
1.49亿
市值:
66.26亿
市盈率:
-20.97
高:
17.390
开:
17.000
低:
15.900
收:
16.660
52周最高:
23.500
52周最低:
4.200
股本:
4.08亿
香港流通股本:
4.08亿
量比:
3.03
换手率:
2.23%
股息:
- -
股息率:
- -
每股收益(LYR):
-0.775
净资产收益率:
-34.59%
总资产收益率:
-19.92%
市净率:
8.53
市盈率(LYR):
-20.97
市销率:
1314.71
数据加载中...
总览
公司
新闻
公告
来凯医药-B(02105)股价下跌5.019%,现价港币$15.14
阿斯达克财经
·
07/09
格隆汇沽空预警榜 | 7月7日
格隆汇
·
07/09
来凯医药-B盘中异动 早盘股价大跌5.06%
市场透视
·
07/08
每日卖空追踪 | 来凯医药-B 07月07日卖空量成交19.9万股,卖空比例为11.13%
市场透视
·
07/07
医药行业周报:正向循环建立 出海趋势强化
华鑫证券
·
07/07
每日卖空追踪 | 来凯医药-B 07月04日卖空量成交32.4万股,卖空比例为7.33%
市场透视
·
07/04
来凯医药-B07月04日主力净流入75.6万元 散户资金抛售
市场透视
·
07/04
中信建投:全球市场极具吸引力 中国创新药全球化产业趋势明确
智通财经
·
07/04
港股异动 | 来凯医药-B(02105)再涨超4% 就LAE103向美国FDA递交新药临床试验申请
智通财经
·
07/04
每日卖空追踪 | 来凯医药-B 07月02日卖空量成交6500股,卖空比例为0.12%
市场透视
·
07/02
来凯医药-B盘中异动 股价大涨5.27%
市场透视
·
07/02
每日卖空追踪 | 来凯医药-B 06月30日卖空量成交5.65万股,卖空比例为1.1%
市场透视
·
06/30
【券商聚焦】太平洋证券维持来凯医药(02105)“买入”评级 指LAE102 SAD安全性优异
金吾财讯
·
06/30
来凯医药-B盘中异动 大幅下挫5.00%报17.100港元
市场透视
·
06/30
来凯医药-B(02105):就LAE103向FDA递交IND申请
智通财经
·
06/30
港股概念追踪 | 首款国产GLP-1双靶点减肥药获批上市 国内多家药企布局减肥药赛道(附概念股)
智通财经
·
06/30
医药行业周报:出海趋势不变 静待机遇
华鑫证券
·
06/30
每日卖空追踪 | 来凯医药-B 06月27日卖空量成交7.4万股,卖空比例为2.01%
市场透视
·
06/27
每日卖空追踪 | 来凯医药-B 06月26日卖空量成交3.3万股,卖空比例为1.02%
市场透视
·
06/26
增肌减脂最强者诞生:礼来Bimagrumab数据惊艳 来凯(02105)LAE102价值上升
智通财经
·
06/26
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02105/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":16.24,"timestamp":1756195699001,"preClose":16.66,"halted":0,"volume":9086000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.774508173090875,"marketStatus":"已收盘","change":-0.42,"latestTime":"08-26 16:08:19","open":17,"high":17.39,"low":15.9,"amount":148510298,"amplitude":0.089436,"askPrice":16.24,"askSize":268000,"bidPrice":16.2,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.7123321584248012,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":16.66,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":3.025278,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.774508,"volumeRatio":3.025278,"shares":408000000,"dividePrice":0,"high":17.39,"amplitude":0.089436,"preClose":16.66,"low":15.9,"week52Low":4.2,"pbRate":"8.53","psRate":"1314.71","week52High":23.5,"institutionHeld":0,"latestPrice":16.24,"committee":-0.988868,"eps":-0.774508173090875,"divideRate":0,"volume":9086000,"delay":0,"ttmEps":-0.7123321584248012,"open":17,"prevYearClose":9.37,"prevWeekClose":17.19,"prevMonthClose":18.8,"prevQuarterClose":17.46,"fiveDayClose":17.98,"twentyDayClose":19.98,"sixtyDayClose":19.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盘后","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754496000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-08-25","current":-24.093478,"percent":0.08818,"low":-30.832985,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"high":-1.640852,"avg":-10.791117,"sd":7.187702,"marketCap":6322695243},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-25","current":-24.093478,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"marketCap":6322695243}],"updateTime":1756186927627},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550250191","title":"来凯医药-B(02105)股价下跌5.019%,现价港币$15.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2550250191","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550250191?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 11:53","pubTimestamp":1752033180,"startTime":"0","endTime":"0","summary":"[下跌股]来凯医药-B(02105) 股价在上午11:53比前收市价下跌5.019%,现股价为港币$15.14。至目前为止,今日最高价为$16.0,而最低价为$15.14。总成交量为153.56万股,总成交金额为港币$2.381千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2507091531/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2550527118","title":"格隆汇沽空预警榜 | 7月7日","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527118","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550527118?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 02:15","pubTimestamp":1751998500,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示,上一交易日大市沽空比例为17.53%,过去两个月大市日均沽空比例为16.18%。其中,华夏沪深三百-R、PP科创50-R、中国海洋石油-R沽空比率排名前三位,分别为100.00%、100.00%、100.00%。南方恒生科技、盈富基金、美团-W的沽空金额排名前三位,分别为34.15亿、29.47亿、20.32亿。361度、力勤资源、美中嘉和的偏离值排名前三位,分别为5.09、3.89、3.87。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/09021551571472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03466","MPNGY","81211","BYDDY","83188","09008","02245","02828","03006","02800","06683","09388","01921","80883","82020","01440","002594","03437","02105","03958","TCHmain","03033","81810","01448","KSTmain","HXXD.SI","HBBD.SI","HYDD.SI","MCHmain","81024","89988","MIUmain","02453","ALBmain","HTCD.SI","01361","03690","HMTD.SI","METmain","83437","83151"],"gpt_icon":1},{"id":"2549094598","title":"来凯医药-B盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549094598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549094598?lang=zh_cn&edition=fundamental","pubTime":"2025-07-08 10:31","pubTimestamp":1751941885,"startTime":"0","endTime":"0","summary":"2025年07月08日早盘10时31分,来凯医药-B股票出现异动,股价大幅下挫5.06%。截至发稿,该股报16.140港元/股,成交量100.05万股,换手率0.25%,振幅6.82%。来凯医药-B股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,正大企业国际、华康生物医学、基石药业-B涨幅较大,振幅较大的相关个股有基石药业-B、北海康成-B、正大企业国际,振幅分别为18.57%、16.28%、13.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708103125a69c15b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708103125a69c15b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2549790587","title":"每日卖空追踪 | 来凯医药-B 07月07日卖空量成交19.9万股,卖空比例为11.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549790587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549790587?lang=zh_cn&edition=fundamental","pubTime":"2025-07-07 16:30","pubTimestamp":1751877028,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月07日,跌1.85%,卖空量成交19.9万股%,较上一交易日减少53.34%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171936a43b8340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171936a43b8340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2549374945","title":"医药行业周报:正向循环建立 出海趋势强化","url":"https://stock-news.laohu8.com/highlight/detail?id=2549374945","media":"华鑫证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549374945?lang=zh_cn&edition=fundamental","pubTime":"2025-07-07 00:00","pubTimestamp":1751817600,"startTime":"0","endTime":"0","summary":"通过双抗,三抗,联用等多个组合,未来PD-1治疗的窗口将一部拓宽,PD-1组合将成为未来肿瘤治疗的新趋势。联邦制药已于6月20日收到诺和诺德对UBT251的首付款,双方围绕UBT251的海外临床方案也进行了讨论,预计2026年海外临床将启动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707074121a43a7be2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707074121a43a7be2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK0188","BK0239","BK0028","BK0096","01530","600993","02105","01801","02171"],"gpt_icon":0},{"id":"2548364230","title":"每日卖空追踪 | 来凯医药-B 07月04日卖空量成交32.4万股,卖空比例为7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548364230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548364230?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 16:30","pubTimestamp":1751617829,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月04日,涨3.84%,卖空量成交32.4万股%,较上一交易日增加356.34%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172200a72e88f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172200a72e88f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2548361379","title":"来凯医药-B07月04日主力净流入75.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2548361379","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548361379?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 16:15","pubTimestamp":1751616912,"startTime":"0","endTime":"0","summary":"07月04日, 来凯医药-B股价涨3.84%,报收17.32元,成交金额7597.8万元,换手率1.09%,振幅7.91%,量比1.06。来凯医药-B今日主力资金净流入75.6万元,上一交易日主力净流出618.9万元。该股近5个交易日下跌1.14%,主力资金累计净流入133.3万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出4174.7万元,其中净流出天数为8日。该股主力净额占比0.01%,港股市场排名295/2666。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165345a72e77aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165345a72e77aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2548071354","title":"中信建投:全球市场极具吸引力 中国创新药全球化产业趋势明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2548071354","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548071354?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 14:35","pubTimestamp":1751610910,"startTime":"0","endTime":"0","summary":"中信建投发布研报称,中国诸多创新药资产近年来逐步进入全球视野,临床数据在各类学术会议上占据越发重要的地位,BD授权金额及数量持续攀升,全球影响力持续扩大。随着中国创新药竞争力持续提升及被发现,将有更多BD交易达成,一批授出项目有望在未来2-3年看到在全球主要市场陆续上市,带动国内创新药企迎来全球化发展加速。全球市场极具吸引力,中国创新药全球化产业趋势明确创新药海外市场规模占据主要地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070414363895362703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070414363895362703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601066","688331","BK0276","LU2148510915.USD","02162","02105","159992","BK0239","LU1064130708.USD","06160","LU2488822045.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2548335373","title":"港股异动 | 来凯医药-B(02105)再涨超4% 就LAE103向美国FDA递交新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548335373","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548335373?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 11:51","pubTimestamp":1751601098,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,来凯医药-B再涨超4%,截至发稿,涨4.2%,报17.38港元,成交额4544.15万港元。消息面上,来凯医药近日公布,集团已就自主研发的LAE103,向美国食品药品监督管理局递交新药临床试验申请,潜在用于治疗肌少性肥胖症及肌肉相关疾病患者。LAE102的中国I期MAD研究已启动,评估皮下给药LAE102在60名超重/肥胖受试者中的安全性、耐受性、PD和PK,预计25Q3数据读出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02105","BK1576","BK1161","03347","BK1141"],"gpt_icon":0},{"id":"2548386799","title":"每日卖空追踪 | 来凯医药-B 07月02日卖空量成交6500股,卖空比例为0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548386799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548386799?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 16:30","pubTimestamp":1751445029,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月02日,跌7.1%,卖空量成交6500股%,较上一交易日减少96.17%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172059a72a490b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172059a72a490b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2548837736","title":"来凯医药-B盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548837736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548837736?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 09:30","pubTimestamp":1751419820,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘09时30分,来凯医药-B股票出现异动,股价大幅上涨5.27%。截至发稿,该股报18.380港元/股,成交量2.7万股,换手率0.01%,振幅4.01%。来凯医药-B股票所在的生物技术行业中,整体涨幅为0.93%。其相关个股中,科笛-B、加科思-B、北海康成-B涨幅较大,振幅较大的相关个股有加科思-B、来凯医药-B、北海康成-B,振幅分别为4.15%、4.01%、3.45%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093020a4c9f3d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093020a4c9f3d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2547062468","title":"每日卖空追踪 | 来凯医药-B 06月30日卖空量成交5.65万股,卖空比例为1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547062468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547062468?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 16:30","pubTimestamp":1751272225,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月30日,跌3%,卖空量成交5.65万股%,较上一交易日减少69.95%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171858a4c64108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171858a4c64108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2547056369","title":"【券商聚焦】太平洋证券维持来凯医药(02105)“买入”评级 指LAE102 SAD安全性优异","url":"https://stock-news.laohu8.com/highlight/detail?id=2547056369","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547056369?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 13:19","pubTimestamp":1751260794,"startTime":"0","endTime":"0","summary":"金吾财讯 | 太平洋证券发报指,来凯医药 LAE102的1期单剂量递增研究为一项双盲、安慰剂对照试验,共招募了64名健康受试者。总体而言,单次LAE102给药的耐受性良好,未报告SAE或导致研究终止的TEAE,也没有报告任何腹泻病例。该机构指,SAD研究中,大多数TEAE为轻度实验室检查异常,无临床症状,无需医疗干预。维持“买入”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1961391","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","161027","601099"],"gpt_icon":0},{"id":"2547345650","title":"来凯医药-B盘中异动 大幅下挫5.00%报17.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547345650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547345650?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 09:42","pubTimestamp":1751247733,"startTime":"0","endTime":"0","summary":"2025年06月30日早盘09时42分,来凯医药-B股票出现波动,股价快速下挫5.00%。截至发稿,该股报17.100港元/股,成交量33.5万股,换手率0.08%,振幅5.11%。机构评级方面,在所有3家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。来凯医药-B股票所在的生物技术行业中,整体跌幅为0.18%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630094213a724e248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630094213a724e248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2547365990","title":"来凯医药-B(02105):就LAE103向FDA递交IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2547365990","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547365990?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 08:40","pubTimestamp":1751244044,"startTime":"0","endTime":"0","summary":"智通财经APP讯,来凯医药-B(02105)发布公告,集团已就自主研发的LAE103(一种针对ActRIIB的单克隆抗体),向美国食品药品监督管理局(FDA)递交了新药临床试验申请,潜在用于治疗肌少性肥胖症及肌肉相关疾病患者。公司将与监管机构密切合作,完成申请流程,并致力于为需要新型治疗方案的代谢疾病患者提供这种精准治疗。集团计画分别评估靶向ActRIIA与ActRIIB受体的单克隆抗体在人体中的疗效及安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2547033197","title":"港股概念追踪 | 首款国产GLP-1双靶点减肥药获批上市 国内多家药企布局减肥药赛道(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2547033197","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547033197?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 07:23","pubTimestamp":1751239421,"startTime":"0","endTime":"0","summary":"据悉,中国已获批了四款GLP-1减肥药上市,分别是利拉鲁肽、贝那鲁肽、司美格鲁肽及替尔泊肽,前两款药物属于短效制剂,生产厂家是国产企业;后两款是长效制剂,为进口药物。恒瑞医药的GLP-1/GIP双靶点药物HRS-7535在Ⅲ期临床试验中取得了显著的减重效果,减重效果达18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1161","BK1574","BK1515","LU2328871848.SGD","YANG","HSTECH","BK1589","LU1969619763.USD","BK4614","BK4590","GLP","02105","BK1583","LU2488822045.USD","HSCEI","01801","BK4144"],"gpt_icon":1},{"id":"2547033022","title":"医药行业周报:出海趋势不变 静待机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2547033022","media":"华鑫证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547033022?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 00:00","pubTimestamp":1751212800,"startTime":"0","endTime":"0","summary":"HS-20094交易的达成,MNC依然关注并继续布局双靶点的注射剂,尤其是辉瑞小分子GLP-1终止临床试验之后,双靶点和三靶点注射剂的安全性依然是突出优势。2月17 日,IBI363治疗鳞状非小细胞肺癌获得FDA快速通道资格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630074224a724aaeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630074224a724aaeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","06978","01530","01672","02171","BK1161","02105","01801","BK1574"],"gpt_icon":0},{"id":"2546971175","title":"每日卖空追踪 | 来凯医药-B 06月27日卖空量成交7.4万股,卖空比例为2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546971175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546971175?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 16:30","pubTimestamp":1751013027,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月27日,涨2.74%,卖空量成交7.4万股%,较上一交易日减少45.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627174316a72094b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627174316a72094b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2546854837","title":"每日卖空追踪 | 来凯医药-B 06月26日卖空量成交3.3万股,卖空比例为1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546854837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546854837?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 16:30","pubTimestamp":1750926626,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月26日,跌2.12%,卖空量成交3.3万股%,较上一交易日减少22.35%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626172401a4bee9bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626172401a4bee9bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2546227035","title":"增肌减脂最强者诞生:礼来Bimagrumab数据惊艳 来凯(02105)LAE102价值上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2546227035","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546227035?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 08:40","pubTimestamp":1750898420,"startTime":"0","endTime":"0","summary":"ActRII增肌减脂药物,当前全球范围除Bimagrumab外,仅有来凯医药LAE102处于临床阶段。Bimagrumab、LAE102作为ActRII通路项目,彼此关系是共存大于竞争,互相强化逻辑。LAE102成为BD大热门。Bimagrumab BELIEVE试验共招募约500名参与者,以大样本数据验证ActRII作用机制。在备受关注的安全性方面,Bimagrumab常见不良反应包括肌肉痉挛、腹泻、痤疮。Bimagrumab惊艳的疗效数据,点亮ActRII通路,在ADA年会之后,中国创新资产LAE102的潜在价值更可高看一眼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1309873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"增肌减脂最强者诞生:礼来Bimagrumab数据惊艳 来凯(02105)LAE102价值上升","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2265009873.SGD","LU2471134879.HKD","LU1868837300.USD","LU0889565916.HKD","BK4585","LU0109394709.USD","LU0058720904.USD","LU2112291526.USD","LU2237443622.USD","IE00BJJMRZ35.SGD","LU2237443465.HKD","LU0316494557.USD","02105","SG9999001176.SGD","LU2237443895.HKD","SG9999018865.SGD","LU2471134796.USD","LU2357305700.SGD","LU1551013342.USD","LU2417539215.USD","LU0417517546.SGD","BK4516","LU2089984988.USD","SG9999014898.SGD","IE00B4R5TH58.HKD","LU0354030438.USD","LU2462157665.USD","LU2471134523.USD","LU0323591593.USD","IE00BJT1NW94.SGD","LU0708995401.HKD","LU1127390331.HKD","LU1814569148.SGD","LU1868837136.USD","LU2237443978.SGD","LU2552382215.SGD","LU0354030511.USD","BK4588","LU1064131342.USD","LU0256863902.USD","LU1366192091.USD","LU2237443549.SGD","LU2237443382.USD","LU0109391861.USD","SG9999015986.USD","LU1868836591.USD","SG9999013999.USD","LU0094547139.USD","IE00BK4W5L77.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":194,"code":"91000000","status":"200"}]}}